Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update
Go back to Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 3.40 -0.04 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.44 | 52 Week High | $3.89 | |||
| Open | $3.33 | 52 Week Low | $1.85 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.33 | EPS | $0.00 | |||
| Volume | 43,653 | |||||
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 3.40 -0.04 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.44 | 52 Week High | $3.89 | |||
| Open | $3.33 | 52 Week Low | $1.85 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.33 | EPS | $0.00 | |||
| Volume | 43,653 | |||||

